logo
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Open Lending Corporation, Civitas Resources, and Avis Budget and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Open Lending Corporation, Civitas Resources, and Avis Budget and Encourages Investors to Contact the Firm

Business Upturn5 hours ago

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Open Lending Corporation (NASDAQ:LPRO), NET Power, Inc. (NYSE:NPWR), Civitas Resources, Inc. (NYSE: CIVI), and Avis Budget Group, Inc. (NASDAQ:CAR). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Open Lending Corporation (NASDAQ:LPRO)
Class Period: February 24, 2022 – March 31, 2025
Lead Plaintiff Deadline: June 30, 2025
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants: (1) misrepresented the capabilities of the Company's risk-based pricing models; (2) issued materially misleading statements regarding the Company's profit share revenue; (3) failed to disclose the Company's 2021 and 2022 vintage loans had become worth significantly less than their corresponding outstanding loan balances; (4) misrepresented the underperformance of the Company's 2023 and 2024 vintage loans; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
For more information on the Open Lending class action go to: https://bespc.com/cases/LPRO
NET Power, Inc. (NYSE:NPWR)
Class Period: June 9, 2023 – March 7, 2025
Lead Plaintiff Deadline: June 17, 2025
Net Power is a clean energy technology company. Its business is centered around its so-called 'Net Power Cycle' technology, which is a purported novel power generation system designed to produce reliable and affordable electricity from natural gas while capturing virtually all atmospheric emissions. Net Power has a facility located in La Porte, Texas, which it uses to demonstrate the viability of the NET Power Cycle, referred to as 'La Porte' or the 'Demonstration Plant.' Net Power conducts research and equipment validation testing campaigns at the Demonstration Plant as part of its efforts to develop its first utility-scale plant, which it variably refers to as 'SN1' or 'Project Permian.' Project Permian is located at a site in the Permian Basin of West Texas. Since before the start of the Class Period, Defendants had represented that they anticipated SN1 to be operational in 2026. In 2023, Net Power's cost estimate for Project Permian was roughly $950 million, which increased to $1.1 billion in 2024. Net Power's commencement of commercial operations and, accordingly, its business and financial prospects, rely on its completion of Project Permian. As such, Defendants' projected timelines and cost estimates for Project Permian are of particular importance to investors and analysts.
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Net Power was unlikely to complete Project Permian on schedule, and the project was likely to be significantly more expensive than Defendants had represented, because of, inter alia, supply chain issues and numerous site- and region-specific challenges; (ii) accordingly, Defendants' projections regarding the time and capital needed to complete Project Permian were unrealistic; (iii) the increased time and capital needed to complete Project Permian were likely to have a significant negative impact on the Company's business and financial results; and (iv) as a result, Defendants' public statements were materially false and misleading at all relevant times.
For more information on the NET Power class action go to: https://bespc.com/cases/NPWR
Civitas Resources, Inc. (NYSE: CIVI)
Class Period: February 27, 2024 – February 24, 2025
Lead Plaintiff Deadline: July 1, 2025
The Civitas Resources class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) Civitas Resources was highly likely to significantly reduce its oil production in 2025 as a result of, among other things, declines following the production peak at the DJ Basin in the fourth quarter of 2024 and a low TIL count at the end of 2024; (ii) increasing its oil production would require Civitas Resources to acquire additional acreage and development locations, thereby incurring significant debt and causing Civitas Resources to sell corporate assets to offset its acquisition costs; (iii) Civitas Resources' financial condition would require it to implement disruptive cost reduction measures including a significant workforce reduction; and (iv) accordingly, Civitas Resources' business and/or financial prospects, as well as its operational capabilities, were overstated.
The Civitas Resources class action lawsuit further alleges that on February 24, 2025, Civitas Resources announced its financial results for the fourth quarter and full year 2024, reporting revenue of $1.29 billion, missing consensus estimates by $3.44 million, and non-GAAP earnings per share of $1.78 for the quarter, missing consensus estimates by $0.21 per share. According to the complaint, also on February 24, 2025, Civitas Resources revealed several 2025 outlook highlights, including '[d]elivering oil production between 150 and 155 thousand barrels per day ('MBbl/d') on average,' – a year-over-year decline of approximately 4% –'[e]xpanding [its] Permian Basin position with a $300 million bolt-on transaction that adds 19,000 net acres and approximately 130 future development locations in the Midland Basin,' and '[e]xecuting on [a] new divestment target of $300 million' meant to offset the foregoing transaction. Civitas Resources explained that '[a]s compared to the fourth quarter of 2024, lower volumes are primarily driven by the DJ Basin, due to natural declines following peak production in the fourth quarter, a low TIL count exiting 2024 and in the first quarter of 2025,' as well as severe winter weather and unplanned third-party processing downtime in the first quarter, the Civitas Resources class action lawsuit alleges. Civitas Resources additionally announced a 10% reduction in its workforce across all levels and the termination of its Chief Operating Officer and Chief Transformation Officer, according to the complaint. On this news, the price of Civitas Resources stock fell more than 18%, according to the Civitas Resources class action lawsuit.
For more information on the Civitas class action go to: https://bespc.com/cases/CIVI
Avis Budget Group, Inc. (NASDAQ:CAR)
Class Period: February 16, 2024 – February 10, 2025
Lead Plaintiff Deadline: June 24, 2025
The lawsuit alleges that Defendants made materially false and misleading statements and/or failed to disclose material adverse information regarding the Company's business, operations, and prospects, including allegations that: (i) Avis Budget crafted and implemented a plan to significantly accelerate its fleet rotation in the fourth quarter of 2024; (ii) the foregoing acceleration shortened the useful life of the majority of the Company's vehicles in the Americas segment, thereby reducing their recoverable value; (iii) as a result, Avis Budget would be forced to recognize billions of dollars in impairment charges and incur substantial losses; (iv) all the foregoing was likely to, and did, have a significant negative impact on the Company's financial results; and (v) accordingly, Avis Budget's financial and/or business prospects were overstated.
For more information on the Avis Budget class action go to: https://bespc.com/cases/CAR
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com . Attorney advertising. Prior results do not guarantee similar outcomes.
Contact Information:
Bragar Eagel & Squire, P.C.Brandon Walker, Esq. Marion Passmore, Esq.(212) 355-4648
[email protected]
www.bespc.com

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Goldman Sachs Hikes Insmed (INSM) Price Target to $112 Affirms Buy Rating
Goldman Sachs Hikes Insmed (INSM) Price Target to $112 Affirms Buy Rating

Yahoo

time36 minutes ago

  • Yahoo

Goldman Sachs Hikes Insmed (INSM) Price Target to $112 Affirms Buy Rating

Insmed Incorporated (NASDAQ:INSM) is . On June 11, Goldman Sachs analyst Andrea Tan reiterated a 'Buy' rating on the stock and increased the price target to $112 from $100. The adjustment underscores the analyst's confidence about the company's long-term prospects. A scientist examining the glucocerebrosidase enzyme development with the aim of establishing therapeutics for Gaucher disease. The Buy rating comes on the heels of the biopharmaceutical company raising $750 million in a public offering of common stock. It plans to use net proceeds from the offering to accelerate research and development efforts of brensocatib. Part of the funds will also finance the commercialization activities of ARIKAYCE. They will also support the development of treprostinil palmitil inhalation powder and other research initiatives. Insmed Incorporated (NASDAQ:INSM) is a global biopharmaceutical company focused on developing and commercializing therapeutics for serious and rare diseases. It focuses on respiratory and rare diseases, specifically emphasizing metabolic diseases and endocrine disorders. While we acknowledge the potential of INSM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Stocks Analysts Are Upgrading Today and 13 Best AI Stocks to Buy Under $10. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

First Aero-Medical Cessna SkyCourier to be Delivered to Tassili Travail Aérien in Africa, Launching New Era of Medevac Services
First Aero-Medical Cessna SkyCourier to be Delivered to Tassili Travail Aérien in Africa, Launching New Era of Medevac Services

Business Wire

time39 minutes ago

  • Business Wire

First Aero-Medical Cessna SkyCourier to be Delivered to Tassili Travail Aérien in Africa, Launching New Era of Medevac Services

PARIS--(BUSINESS WIRE)-- Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, announced today at the Paris Air Show that Tassili Travail Aérien (TTA) has signed a purchase agreement for two new Cessna SkyCourier aircraft, marking the first order of an aero-medical equipped SkyCourier and the first SkyCourier order in Africa. Tassili Travail Aérien (TTA) has signed a purchase agreement for two new Cessna SkyCourier aircraft, marking the first order of an aero-medical equipped SkyCourier and the first SkyCourier order in Africa. Based in Algeria, TTA is a subsidiary of Sonatrach, the national state-owned oil and gas company. TTA provides passenger transportation, aero-medical evacuation, and other special mission services to the energy sector across Algeria. The Cessna SkyCourier is designed and manufactured by Textron Aviation. 'The Cessna SkyCourier is a versatile aircraft capable of supporting challenging missions, high payloads and short, rough runways worldwide,' said Bob Gibbs, vice president, Special Mission Sales. 'TTA's mission package includes the advanced Lifeport PLUS Powered Medevac System, allowing TTA to quickly switch from passenger or cargo to medevac missions.' The twin-engine, large utility Cessna SkyCourier turboprop will modernize TTA's fleet, offering improved efficiency and reliability, and lower operating costs, while supporting transportation and medevac missions. The aircraft will be based in Algiers and Hassi Messaoud, Algeria, and delivery is anticipated in 2026. Endless Special Missions Possibilities When government, military and commercial customers want airborne solutions for critical missions, they turn to Textron Aviation. The company's aviation solutions provide the high-performance and flight characteristics required to address the unique challenges of special missions operations. With unparalleled quality, versatility and low operating costs, Textron Aviation products are ideal for air ambulance, intelligence, surveillance and reconnaissance (ISR); utility transport, aerial survey, flight inspection; training and many other special operations. About the Cessna SkyCourier The Cessna SkyCourier twin-engine, high-wing turboprop offers a combination of performance and lower operating costs for air freight, commuter and special mission operators. It's available in both freighter and passenger variants, as well as a Combi configuration or with a gravel kit for maximum flexibility. The 19-passenger variant includes separate crew and passenger doors for smooth boarding, a large baggage compartment and large cabin windows for natural light and views. The freighter variant features a flat-floor cabin that is sized to handle up to three LD3 shipping containers with an impressive 6,000 pounds of payload capability. Both variants offer a large cargo door and single-point pressure refueling to enable faster turnarounds. The aircraft is powered by two wing-mounted Pratt & Whitney Canada PT6A-65SC turboprop engines and features the McCauley Propeller C779, a heavy-duty and reliable 110-inch aluminum four-blade propeller, which is full feathering with reversible pitch, designed to enhance the performance of the aircraft while hauling tremendous loads. The SkyCourier is operated with Garmin G1000 NXi avionics and has a maximum cruise speed of more than 200 ktas and a 900 nautical-mile maximum range. About Textron Aviation We inspire the journey of flight. For more than 95 years, Textron Aviation has empowered our collective talent across the Beechcraft, Cessna and Hawker brands to design and deliver the best aviation experience for our customers. With a range that includes everything from business jets, turboprops and high-performance pistons, to special missions, military trainer and defense products, Textron Aviation has the most versatile and comprehensive aviation product portfolio in the world and a workforce that has produced more than half of all general aviation aircraft worldwide. Customers in more than 170 countries rely on our legendary performance, reliability and versatility, along with our trusted global customer service network, for affordable, productive and flexible flight. For more information, visit | | | About Textron Inc. Textron Inc. is a multi-industry company that leverages its global network of aircraft, defense, industrial and finance businesses to provide customers with innovative solutions and services. Textron is known around the world for its powerful brands such as Bell, Cessna, Beechcraft, Pipistrel, Jacobsen, Kautex, Lycoming, E-Z-GO, and Textron Systems. For more information, visit: Certain statements in this press release may project revenues or describe strategies, goals, outlook or other non-historical matters; these forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update them. These statements are subject to known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements, including, but not limited to, changes in aircraft delivery schedules or cancellations or deferrals of orders.

RAPT Therapeutics to Participate in Upcoming Investor Conferences
RAPT Therapeutics to Participate in Upcoming Investor Conferences

Business Insider

timean hour ago

  • Business Insider

RAPT Therapeutics to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that members of the RAPT management team will participate in the following investor conferences in June: Goldman Sachs 46th Annual Global Healthcare Conference – Fireside chat on Tuesday, June 10, 2025 at 9:20 a.m. ET UBS Spring Biotech Conference – Investor one-on-one meetings on Tuesday, June 24, 2025 To access the live webcast or subsequent archived recording of the Goldman Sachs fireside chat, please visit the RAPT Therapeutics website at About RAPT Therapeutics, Inc. RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases. Utilizing our deep and proprietary expertise in immunology, we develop novel therapies that are designed to modulate the critical immune responses underlying these diseases.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store